5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.81▼ | 2.84▼ | 2.86▼ | 2.73▲ | 2.82▼ |
MA10 | 2.82▼ | 2.90▼ | 2.90▼ | 2.76▼ | 3.60▼ |
MA20 | 2.84▼ | 2.90▼ | 2.77▼ | 2.80▼ | 4.42▼ |
MA50 | 2.90▼ | 2.74▲ | 2.74▲ | 3.70▼ | 5.54▼ |
MA100 | 2.89▼ | 2.75▼ | 2.80▼ | 4.50▼ | 6.14▼ |
MA200 | 2.76▼ | 2.82▼ | 3.33▼ | 5.22▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.004▼ | -0.027▼ | 0.000▼ | 0.056▲ | -0.190▼ |
RSI | 27.744▼ | 42.744▼ | 47.754▼ | 41.908▼ | 32.020▼ |
STOCH | 20.022 | 11.957▼ | 48.009 | 28.666 | 13.029▼ |
WILL %R | -100.000▼ | -100.000▼ | -63.636 | -62.195 | -91.667▼ |
CCI | -256.871▼ | -204.059▼ | -60.375 | 40.300 | -105.614▼ |
Thursday, May 01, 2025 07:00 AM
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has received FDA approval to move forward with its Virtue Trial, a pivotal clinical study designed to evaluate its next-generation ...
|
Thursday, May 01, 2025 01:00 AM
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced its participation in the upcoming Jefferies Global Healthcare Conference, which will be held in New York, NY, on ...
|
Tuesday, April 29, 2025 07:46 AM
Orchestra BioMed (Nasdaq:OBIO) announced that it received FDA investigational device exemption (IDE) for its Virtue drug-coated balloon.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 3.12 | 3.12 | 2.75 | 2.75 | 404,520 |
30/04/25 | 2.62 | 3.03 | 2.58 | 2.97 | 796,776 |
29/04/25 | 2.67 | 2.67 | 2.44 | 2.53 | 389,828 |
28/04/25 | 2.74 | 2.88 | 2.5925 | 2.61 | 272,118 |
25/04/25 | 2.62 | 2.85 | 2.55 | 2.78 | 292,294 |
24/04/25 | 2.81 | 2.81 | 2.52 | 2.58 | 308,331 |
23/04/25 | 2.91 | 3.09 | 2.77 | 2.85 | 646,088 |
22/04/25 | 3.13 | 3.24 | 2.53 | 2.86 | 14,156,422 |
21/04/25 | 2.75 | 3.0287 | 2.75 | 2.84 | 56,365 |
17/04/25 | 2.86 | 2.949 | 2.77 | 2.85 | 41,109 |
|
|
||||
|
|
||||
|
|